Answers are grounded in this paper and cite their sources.
Antimicrobial resistance (AMR) poses a severe global public health threat, particularly in low- and middle-income countries like Bangladesh, where factors such as unregulated antibiotic use, weak surveillance, and inadequate healthcare infrastructure exacerbate the problem. A unified, up-to-date assessment of recent resistance trends is crucial to guide effective public health interventions and optimize clinical decision-making. This systematic review and meta-analysis aimed to evaluate the prevalence and antimicrobial resistance patterns of major clinical bacterial pathogens in Bangladesh between 2019 and 2024. The analysis followed PRISMA guidelines, with data sourced from PubMed, Google Scholar, ResearchGate, and DOAJ. A random-effects model was employed to synthesize data from 30 eligible studies encompassing over 270,000 clinical specimens, providing estimates for the pooled prevalence and resistance patterns of eight major bacterial pathogens. Median resistance (MR) and interquartile ranges (IQR) were also calculated to determine resistance levels for each pathogen–antibiotic pair. The findings revealed that Gram-negative bacteria were most prevalent, with Escherichia coli (12%), Klebsiella spp. (8%), and Pseudomonas spp. (7%) as the most common pathogens. Alarmingly high antibiotic resistance rates were observed across all species, particularly in Enterococcus spp. (70%), Pseudomonas spp. (56%), Acinetobacter spp. (53%), E. coli (46%), Proteus spp. (44%), Staphylococcus aureus (43%), Klebsiella spp. (41%), and Enterobacter spp. (40%). Resistance was notably high for conventional antibiotics such as β-lactams, cephalosporins, and fluoroquinolones, while concerning levels of resistance were also detected against last-resort antibiotics including carbapenems, colistin, and certain aminoglycosides. These findings highlight the urgent need for national antimicrobial stewardship programs, enhanced surveillance, and coordinated public health strategies to mitigate the escalating threat of AMR.
No takes yet. Share an insight, caveat, or question.
Acharjee et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: